Plasma free carnitine in severe trauma: Influence of the association with traumatic brain injury.

Fanny Vardon Bounes, Géraldine Faure, Antoine Rouget, Jean-Marie Conil, Bernard Georges, Thomas Geeraerts, Olivier Fourcade, Vincent Minville, Clément Delmas

Journal: Injury 2018;49(3):538-542

PMID: 29162266

Abstract

BACKGROUND

Metabolic response to severe trauma requires early nutritional resuscitation. Carnitine is essential for lipolysis, the energy source during this hypercatabolic phase. However l-carnitine is not present in nutritional replacement solutions. Furthermore, free carnitine depletion, defined as carnitine plasma level under 36μmol/L, was not adequately reported in adult patients with severe trauma. The aim of this study was to assess plasma free carnitine levels and factors of variation in severe trauma.

METHOD

Our observational study concerned 38 trauma patients including 18 with traumatic brain injury (TBI). On the third day after trauma, plasma free carnitine concentration was determined (by enzymatic method) while patients received artificial nutrition.

RESULTS

Low plasmatic free carnitine concentration was evidenced in 95% of the patients with a median value of 18μmol/L (11-47). Univariate analysis showed that mean arterial pressure, serum urea, CKD-EPI and patients with TBI were significantly associated with plasma free carnitine concentration less than 18μmol/L. Lower plasma free carnitine concentration was observed in the group of patients with TBI with 17.72μmol/L (11-36) versus 21.5μmol/L (11-47) for others patients (p=0.031). Logistic regression analysis showed that severe trauma with TBI and CKD-EPI above 94mL/min/1.73m2 appeared to be independent predictor of lower free carnitine plasmatic concentration (Goodness of fit=0.87 and AUC=0.89).

CONCLUSION

Our observations support hypotheses that plasma free carnitine concentration is lowered in severe injured patients especially for TBI patients and patients with estimated GFR above 94mL/min/1.73m.

Copyright © 2017 Elsevier Ltd. All rights reserved.

Address: Critical Care Unit, Toulouse University Hospital, Avenue du Pr Jean Poulhès, 31059 Toulouse, France; Institut des Maladies Métaboliques et Cardiovasculaires, INSERM U1048, Université Paul Sabatier, Avenue du Pr Jean Poulhès, 31059 Toulouse, France. Electronic address: [email protected].; Critical Care Unit, Toulouse University Hospital, Avenue du Pr Jean Poulhès, 31059 Toulouse, France. Electronic address: [email protected].; Critical Care Unit, Toulouse University Hospital, Avenue du Pr Jean Poulhès, 31059 Toulouse, France. Electronic address: [email protected].; Critical Care Unit, Toulouse University Hospital, Avenue du Pr Jean Poulhès, 31059 Toulouse, France. Electronic address: [email protected].; Critical Care Unit, Toulouse University Hospital, Avenue du Pr Jean Poulhès, 31059 Toulouse, France. Electronic address: [email protected].; Critical Care Unit, Toulouse University Hospital, Avenue du Pr Jean Poulhès, 31059 Toulouse, France. Electronic address: [email protected].; Critical Care Unit, Toulouse University Hospital, Avenue du Pr Jean Poulhès, 31059 Toulouse, France. Electronic address: [email protected].; Critical Care Unit, Toulouse University Hospital, Avenue du Pr Jean Poulhès, 31059 Toulouse, France; Institut des Maladies Métaboliques et Cardiovasculaires, INSERM U1048, Université Paul Sabatier, Avenue du Pr Jean Poulhès, 31059 Toulouse, France. Electronic address: [email protected].; Critical Care Unit, Toulouse University Hospital, Avenue du Pr Jean Poulhès, 31059 Toulouse, France; Institut des Maladies Métaboliques et Cardiovasculaires, INSERM U1048, Université Paul Sabatier, Avenue du Pr Jean Poulhès, 31059 Toulouse, France. Electronic address: [email protected].
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.